Učitavanje...
CD137 stimulation enhances the vaccinal effect of anti-tumor antibodies
Some evidence suggests that monoclonal antibodies (mAb) can induce an adaptive immune response against tumor cells (“vaccinal effect”). Recently, we have shown that an anti-CD137 mAb can enhance the “vaccinal effect” of an anti-tumor mAb (cetuximab), thereby transforming a passive, monoclonal, short...
Spremljeno u:
| Izdano u: | Oncoimmunology |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292240/ https://ncbi.nlm.nih.gov/pubmed/25610724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.941740 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|